DiannaLShipleyMD

Oncology • Gallatin, TN

Hematologic Oncology

Tennessee Oncology

Join to view full profile

Dr. Shipley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Shipley's full profile

Already have an account?

Office
225 Big Station Camp Road
Ste 201
Gallatin, TN 37066
Phone+1 615-451-5481
Is this information wrong?

Education & Training

Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1993 - 1995
Allegheny Health Network Medical Education Consortium (AGH)Internship, Internal Medicine, 1992 - 1993
Marshall University Joan C. Edwards School of MedicineClass of 1992

Certifications & Licensure

TN State Medical License 1999 - 2025
NC State Medical License 1996 - 2000
WV State Medical License 1993 - 1999
PA State Medical License 1992 - 1993
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

6 citations
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer
Denise A. Yardley, Dianna Shipley, John D. Zubkus, Gail Lynn Shaw Wright, Patrick J. Ward, Aruna Mani, Mythili Shastry, L Finney, Laura M. DeBusk, John D. Hainsworth> ;Clinical Breast Cancer. 2019 Feb 1
3 citations
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
David R. Spigel, John D. Hainsworth, Dianna Shipley, Tarek Mekhail, John D. Zubkus, David M. Waterhouse, Davey B. Daniel, Howard A. Burris, F. Anthony Greco> ;Lung Cancer. 2018 Mar 1
10 citations
Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non–small cell lung cancer and an...
David R. Spigel, John D. Hainsworth, Mathew John Joseph, Dianna Shipley, M. Kelly Hagan, Dana S. Thompson, Howard A. Burris, F. Anthony Greco> ;Cancer. 2018 May 1
38 citations
A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial
Andrew H. Ko, Patrick B. Murphy, James D. Peyton, Dianna Shipley, Ahmed Al-Hazzouri, Francisco Antonio Rodriguez, Mark Sanders Womack, Henry Q. Xiong, David M. Waterho...> ;The Oncologist. 2017 Dec 1
9 citations
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the ...
David R. Spigel, Mark S. Rubin, Victor G. Gian, Dianna Shipley, Howard A. Burris, Rebecca A. Kosloff, Kent C. Shih, Raven Quinn, F. Anthony Greco, John D. Hainsworth> ;Lung Cancer. 2017 Nov 1
6 citations
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal ...
Johanna C. Bendell, Mathew John Joseph, Kirk Barnes, Mark Mainwaring, Dianna Shipley, Chandra Reddy, Laura Blakely, Ronald Blachly, Cassie M. Lane, Chris Earwood, Mich...> ;Cancer Investigation. 2017 Apr 20
14 citations
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer
Denise A. Yardley, Dianna Shipley, N. W. Peacock, Mythili Shastry, Rajiv Midha, Victor M. Priego, John D. Hainsworth> ;Breast Cancer Research and Treatment. 2015 Jul 9
7 citations
High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium
John D. Hainsworth, Dianna Shipley, James A. Reeves, Edward Arrowsmith, Edward K. Barnes, David M. Waterhouse> ;Clinical Genitourinary Cancer. 2013 Sep 1
32 citations
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer☆☆☆
David R. Spigel, F. Anthony Greco, Mark S. Rubin, Dianna Shipley, D. S. Thompson, Eric T. Lubiner, Janice F. Eakle, Raven Quinn, Howard A. Burris, John D. Hainsworth> ;Lung Cancer. 2012 Aug 1
47 citations
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck:...
John D. Hainsworth, David R. Spigel, F. Anthony Greco, Dianna Shipley, James D. Peyton, Mark A. Rubin, Michael A. Stipanov, A. A. Meluch> ;Cancer Journal. 2011 Sep 1
TITAN: Ixabepilone versus weekly paclitaxel following doxorubicin/cyclophosphamide (AC) adjuvant chemotherapy in triple-negative breast cancer (TNBC): Preliminary toxi...
Yardley DA, Hainsworth JD, Harwin WN, Goble SA, Daniel BR, Ackerman MA, Shipley D, Drosick DR, Hanson SE, Griner PL, Burris HA> ;J. Clin. Oncol.. 2011-05-20
High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase II trial.
Meluch AA, Shipley D, Waterhouse DM, Reeves JA, Arrowsmith E, Spigel DR, Hainsworth JD> ;J. Clin. Oncol.. 2011-05-20
9 citations
A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer
David R. Spigel, F. Anthony Greco, Howard A. Burris, Dianna Shipley, Bobby L. Clark, Robert C. Whorf, Edward Arrowsmith, John D. Hainsworth> ;Clinical Lung Cancer. 2011 May 1
19 citations
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage...
Yardley, D. A., Burris, H. A., Peacock, N., Raefsky, E., Melnik, M., Inhorn, R., Shipley, D., Hainsworth, J. D.> ;Breast cancer research and treatment. 2010 Jul 27
7 citations
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
David R. Spigel, F. Anthony Greco, David M. Waterhouse, Dianna Shipley, Cassie M. Lane, Elizabeth R. Vazquez, Bobby L. Clark, Jeffrey R. Infante, Johanna C. Bendell, H...> ;Clinical Advances in Hematology & Oncology. 2010 Jul 1
12 citations
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology ...
John D. Hainsworth, David R. Spigel, Howard A. Burris, Dianna Shipley, C. Farley, Ines M. Macias-Perez, John H. Barton, F. Anthony Greco> ;Cancer. 2010 May 15
14 citations
A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer
Denise A. Yardley, Howard A. Burris, David R. Spigel, Bobby L. Clark, Elizabeth R. Vazquez, Dianna Shipley, J. H. Barton, D. S. Thompson, Ignacio Montes, F. Anthony Gr...> ;Clinical Breast Cancer. 2009 Nov 1
48 citations
Rituximab plus Short-Duration Chemotherapy Followed by Yttrium-90 Ibritumomab Tiuxetan as First-Line Treatment for Patients with Follicular Non-Hodgkin Lymphoma: A Pha...
John D. Hainsworth, David R. Spigel, Tiffanie M. Markus, Dianna Shipley, Dana S. Thompson, Richard Rotman, Charles Dannaher, F. Anthony Greco> ;Clinical Lymphoma & Myeloma. 2009 Jun 1
Randomized phase III comparison of paclitaxel/carboplatin/etoposide versus gemcitabine/irinotecan, both followed by gefitinib, in patients (pts) with carcinoma of unkn...
Hainsworth JD, Lane C, Spigel DR, Shipley D, Waterhouse D, Bury M, Greco FA> ;J. Clin. Oncol.. 2009-05-20
Combined modality therapy with radiation therapy (RT), chemotherapy, bevacizumab, and erlotinib in the treatment of patients (pts) with locally advanced squamous carci...
Meluch AA, Spigel D, Burris HA, Lane C, Peyton JD, Shipley D, Rubin M, Stipanov M, Greco FA, Hainsworth JD> ;J. Clin. Oncol.. 2009-05-20
Efficacy results from a multicenter phase II noncomparative two-arm pilot trial of bevacizumab with anastrozole or fulvestrant as first-line endocrine therapy for meta...
Rubin MS, Barton J, Shipley D, Arrowsmith E, Peacock N, Hart L, Evans J, Vasquez E, Burris HA, Yardley DA> ;J. Clin. Oncol.. 2009-05-20
28 citations
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head an...
John D. Hainsworth, David R. Spigel, Howard A. Burris, Tiffanie M. Markus, Dianna Shipley, Michel E. Kuzur, Scott D. Lunin, F. Anthony Greco> ;Cancer. 2009 May 15
28 citations
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
Denise A. Yardley, Howard A. Burris, L. Simons, David R. Spigel, F. Anthony Greco, J. H. Barton, Dianna Shipley, David Drosick, John D. Hainsworth> ;Clinical Breast Cancer. 2008 Oct 1
Phase II trial of high-dose weekly topotecan in patients with relapsed small-cell lung cancer (SCLC).
Shipley D, Spigel DR, Hainsworth JD, Whorf RC, Markus TM, Kuzur M, Infante JR, Yardley DA, Burris HA, Greco FA> ;J. Clin. Oncol.. 2008-05-20
9 citations
A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer
Suzanne F. Jones, D. S. Thompson, J. H. Barton, Jeff Patton, Dianna Shipley, F. Anthony Greco, David R. Spigel, Jeff Infante, Howard A. Burris> ;Clinical Lung Cancer. 2008 May 1
Join now to see all

Hospital Affiliations

TriStar Centennial Medical CenterNashville, Tennessee
Ascension Saint ThomasNashville, Tennessee
TriStar Skyline Medical CenterNashville, Tennessee